Comparing local vs systemic methotrexate for uterine ectopic pregnancy
Part of Women’s health & pregnancy clinical trials.
This trial compares giving methotrexate (a medicine that stops the pregnancy from growing) locally (injected near the pregnancy) versus systemically (as a shot in your muscle) to treat an ectopic pregnancy in the uterus. It aims to find which way is safer and works better, with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 40 years old.
- You have an ectopic pregnancy located in the uterus (cervix, cesarean scar, or interstitial area).
- Your pregnancy is less than 9 weeks, the embryo is smaller than 10 mm, and your beta-hCG level is between 1,500 and 10,000 mIU/mL.
- You do not have liver or kidney problems, low platelets, diabetes, severe bleeding, a history of cancer, or fluid in your abdomen or lungs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines—letrozole and methotrexate—to see which works better for treating ectopic pregnancy (a pregnancy growing outside the uterus) without surgery. Both medicines may help your body safely end the pregnancy.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This study looks at using methotrexate (a medication) to treat ectopic pregnancy (a pregnancy outside the uterus) in women who have some health issues that might make the usual treatment riskier. It aims to see how well methotrexate works for them.
This trial tests whether letrozole (a hormone-blocking pill) can treat an ectopic pregnancy safely and effectively, allowing you to keep your ability to have children. It is an alternative to methotrexate, and you'll be randomly assigned to one of the two treatments.
This trial compares two treatments for a pregnancy that has implanted in a previous cesarean scar. It tests whether an injection of methotrexate works as well as surgery to end the pregnancy safely.
This study looks at how blood flow patterns around an ectopic pregnancy (pregnancy outside the uterus, in the fallopian tube) might predict whether medication or watchful waiting will work for you. Ectopic pregnancies cannot result in a baby and need treatment; this research aims to help doctors choose the best approach.
Hear when a new Methotrexate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.